Growth via Acquisition Devicare is pursuing growth through strategic M&A, including an announced plan to acquire IP-6 International, which signals potential for cross-sell opportunities, expanded geographic reach (notably North America), and increased demand for digital health solutions in urology.

North America Expansion Recent funding and acquisition activities indicate a clear push to enter or strengthen presence in the North American market, presenting opportunities to position digital therapeutics and nutritionally integrated urology therapies to US healthcare providers and payers.

Financial Backing Signal COFIDES loan funding and venture investments point to growing financial backing, which can be leveraged to secure pilot programs or paid trials with healthcare facilities, offering a pathway to rapid deployment of Devicare’s Lit-Control app and related digital health solutions.

Digital Health Focus Devicare combines nutritional therapy with digital technologies in urology, suggesting opportunity to cross-sell to urology clinics, hospitals, and DTx platforms seeking integrated digital treatment modalities and remote patient monitoring.

Strategic Partnerships Past collaborations with Idneo and Diem Labs indicate a readiness to partner for manufacturing, US market entry, and digital solution deployment, opening doors for co-development, integration projects, and channel partnerships with healthcare technology providers.